Changes in Beneficial Ownership · 4
Vanda Pharmaceuticals Inc.
VNDANASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
ownership.xml
Filing details
- Report period
- 2026-06-04
- Issuer
- Vanda Pharmaceuticals Inc.
- Issuer CIK
- 0001347178
- Trading symbol
- VNDA
Reporting owner 1
- Name
- Duncan Charles Cliff
- Reporting owner CIK
- 0002130896
- Relationship
- Director
- Address
- 2200 PENNSYLVANIA AVENUE NW, SUITE 300E, WASHINGTON, DC, 20037
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | 2026-06-04 | A · Form 4 | 41,600[F1] | A | 0 | 98,701 | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
Footnotes
- F1
- Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 4, 2027, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.↩ 1
Signature 1
- Signed
- /s/ Charles Cliff Duncan
- Date
- 2026-06-08